NEU 5.31% $14.80 neuren pharmaceuticals limited

Apologies for not being clear. My analysis stands. Acadia has a...

  1. 51 Posts.
    lightbulb Created with Sketch. 36
    Apologies for not being clear. My analysis stands. Acadia has a veto right as I noted that manifests itself when Acadia develops Trofinetide for the same indication. Acadia’s monetization of its veto right is Acadia’s contractual right. Why would exercise of Acadia’s contractual rights be considered ABSURD?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.80
Change
-0.830(5.31%)
Mkt cap ! $1.891B
Open High Low Value Volume
$15.65 $15.72 $14.76 $11.61M 772.4K

Buyers (Bids)

No. Vol. Price($)
1 1392 $14.80
 

Sellers (Offers)

Price($) Vol. No.
$14.90 1553 2
View Market Depth
Last trade - 16.10pm 19/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.